Annual Drug Patent Expirations for ZEGALOGUE+%28AUTOINJECTOR%29
Zegalogue (autoinjector) is a drug marketed by Zealand Pharma and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug.
This drug has thirty-one patent family members in twenty-four countries.
The generic ingredient in ZEGALOGUE (AUTOINJECTOR) is dasiglucagon hydrochloride. Two suppliers are listed for this compound. Additional details are available on the dasiglucagon hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
